| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |